Incubated by Flagship Pioneering, Generate applies AI to teasing out the three-dimensional structure of human proteins, ...

With an oversubscribed trading debut now in the books, Veradermics—developing an oral version of the molecule behind ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to ...

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved ...

By Arasu Kannagi Basil and Pritam Biswas Jan 20 (Reuters) - Clear Street recorded a 160% revenue jump in the first nine months of 2025, the Wall Street firm revealed on Tuesday in its U.S. initial ...

Once Upon a Farm had annual sales of $226 million as of Sept. 30, 2025, and incurred a loss of $52 million during the period, ...

Hong Kong’s market regulator stepped up warnings to investment banks over filing sloppy applications for share sales as ...

Exxel Pharma is eyeing a listing on the NYSE American to fund human trials for a drug class that has previously struggled to ...

Grayscale dropped its public IPO filing with the U.S. Securities and Exchange Commission on Thursday, thanks to a confidence boost from so-called crypto president Donald Trump. Sadly, the filing also ...

As the AI boom continues, talk of a potential OpenAI IPO is accelerating in the United States. This talk accelerated recently after a report by Reuters showed that the company was preparing for a $1 ...

Bain Capital-backed Dhoot Transmission, a manufacturer in the auto components sector, has confidentially filed its DRHP with ...

Anaplan, a business-planning software provider owned by private equity firm Thoma Bravo, is taking steps toward an initial ...